ATORVASTATIN
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01076 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 12 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hyperlipoproteinemia | TxGNN Knowledge Graph |
| 2 | hypertriglyceridemia (disease) | TxGNN Knowledge Graph |
| 3 | cerebral infarction | TxGNN Knowledge Graph |
| 4 | cerebrovascular disorder | TxGNN Knowledge Graph |
| 5 | obsolete susceptibility to ischemic stroke | TxGNN Knowledge Graph |
| 6 | obsolete familial combined hyperlipidemia | TxGNN Knowledge Graph |
| 7 | hyperlipidemia, familial combined, LPL related | TxGNN Knowledge Graph |
| 8 | Prinzmetal angina | TxGNN Knowledge Graph |
| 9 | homozygous familial hypercholesterolemia | TxGNN Knowledge Graph |
| 10 | arteriosclerosis disorder | TxGNN Knowledge Graph |
| 11 | stroke disorder | TxGNN Knowledge Graph |
| 12 | atherosclerosis | TxGNN Knowledge Graph |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.